Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron® A)
✍ Scribed by Paul A. Volberding; Ronald T. Mitsuyasu; James P. Golando; Robert J. Spiegel
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 564 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis
Studies of the effect of interferon on the growth of colonies of myeloid leukemic blasts, myeloma colony-forming cells and normal hemopoietic precursor cells have shown that interferon does not specifically inhibit the growth of the malignant cells in culture, i.e. the growth of the malignant and th